Great Tree Pharmacy CoROCO:6469 +1.99%70 Altman Z-Score is 2.60 as of Jul. 06, 2026, which is 33% below its 10-year median of 3.86. GuruFocus rates ROCO:6469 with a GF Score™ of 70/100 and a GF Value™ of NT$193.04 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 661 Healthcare Providers & Services companies, Great Tree Pharmacy Co ranks better than 52.8% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Warning Sign:
Altman Z-score of 2.6 is in the grey area. This implies that the company is under some kind of financial stress. If it is below 1.8, the company may face bankruptcy risk.
Great Tree Pharmacy Co has a Altman Z-Score of 2.60, indicating it is in Grey Zones. This implies that Great Tree Pharmacy Co is in some kind of financial stress. If it is below 1.81, the company may face bankrupcy risk.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Great Tree Pharmacy Co's Altman Z-Score or its related term are showing as below:
ROCO:6469'
s Altman Z-Score Range Over the Past 10 Years
Min: 2.32 Med: 3.86 Max: 5.41
Current: 2.6
During the past 13 years, Great Tree Pharmacy Co's highest Altman Z-Score was 5.41. The lowest was 2.32. And the median was 3.86.
Great Tree Pharmacy Co (ROCO:6469) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
Great Tree Pharmacy Co Altman Z-Score Related Terms
Great Tree Pharmacy Co Altman Z-Score Historical Data
* Premium members only.
The historical data trend for Great Tree Pharmacy Co's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Great Tree Pharmacy Co Altman Z-Score Competitor Comparison
For the Pharmaceutical Retailers subindustry, Great Tree Pharmacy Co's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Great Tree Pharmacy Co Altman Z-Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Great Tree Pharmacy Co's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Great Tree Pharmacy Co's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Great Tree Pharmacy Co (ROCO:6469) has a Altman Z-Score of 2.60 as of Jul. 06, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Great Tree Pharmacy Co and its competitors. This is 33% below median its historical median of 3.86. Over the past decade, Great Tree Pharmacy Co's Altman Z-Score has ranged from 2.32 to 5.41. According to the industry distribution chart, Great Tree Pharmacy Co ranks #312 out of 661 companies in the Healthcare Providers & Services industry, placing it in the top 47.2%.
Is Great Tree Pharmacy Co's Altman Z-Score too high?
Great Tree Pharmacy Co's current Altman Z-Score of 2.60 is 33% below median its 10-year median of 3.86. Over the past 10 years, this metric has ranged from a low of 2.32 to a high of 5.41. The Healthcare Providers & Services industry median Altman Z-Score is 2.47. Great Tree Pharmacy Co's value of 2.60 is 5.3% above this industry median. Based on the distribution chart, Great Tree Pharmacy Co ranks #312 out of 661 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Great Tree Pharmacy Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Great Tree Pharmacy Co's Altman Z-Score compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Great Tree Pharmacy Co ranks #312 out of 661 companies for Altman Z-Score. This puts Great Tree Pharmacy Co in the upper half of its industry. The industry median Altman Z-Score is 2.47. Great Tree Pharmacy Co's value of 2.60 is 5.3% above this benchmark. Historically, Great Tree Pharmacy Co's own Altman Z-Score has ranged from 2.32 to 5.41 over the past decade. While the company's 10-year median is 3.86 vs. the industry median of 2.47, Great Tree Pharmacy Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Healthcare Providers & Services company?
The median Altman Z-Score among Healthcare Providers & Services companies is 2.47, based on 661 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Great Tree Pharmacy Co's current Altman Z-Score of 2.60 is 5.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Great Tree Pharmacy Co and its competitors. For the Healthcare Providers & Services industry, the median Altman Z-Score is 2.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Great Tree Pharmacy Co's current Altman Z-Score is 2.60, which is 33% below median its own 10-year median of 3.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Great Tree Pharmacy Co stock overvalued right now?
Based on GuruFocus' analysis, Great Tree Pharmacy Co (ROCO:6469) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$193.04, compared to a current price of NT$76.70 — trading 60.3% below its estimated fair value. The current Altman Z-Score is 2.60, which is 33% below median its 10-year median of 3.86 and 5.3% above the Healthcare Providers & Services industry median of 2.47. Great Tree Pharmacy Co's overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Great Tree Pharmacy Co (ROCO:6469), the current Altman Z-Score is 2.60 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Great Tree Pharmacy Co (ROCO:6469) Overvalued in 2026?
Based on GuruFocus' analysis, Great Tree Pharmacy Co stock appears to be undervalued.
The current stock price of NT$76.70 is trading 60.3% below its estimated GF Value™ of NT$193.04.
GuruFocus considers Great Tree Pharmacy Co to be Significantly Undervalued.
Key valuation signals for ROCO:6469:
Altman Z-Score: 2.60 (33% below median its 10-year median of 3.86)
GF Value™: NT$193.04 vs. price of NT$76.70 (60.3% below fair value)
Industry Position: 5.3% above the Healthcare Providers & Services median (#312 of 661)
No single metric tells the full story. See the ROCO:6469 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Great Tree Pharmacy Co Ltd engages in management and trading of various drugs, health supplements, maternity and infant products, and cosmetics products. It also provides coordinated medicine procurement services to various clinics, outpatient centers, and medical communities. Besides, it is also an agency for domestic and foreign health care products sold in clinics, outpatient centers, and medical communities. Its products include infant formula, baby diapers, Maternal and Infant Related, Adult drinks, Nutrition and health care, Body care, Daily Necessities, medical equipment, and Pet products.
70GF Score
Get the complete analysis for ROCO:6469
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6469 has been successfully added to your 
